Novo Nordisk will slash Ozempic price for some, ‘aligning’ with generics – Global News

May 26, 2026

Some Canadians will be able to buy brand-name GLP-1 drug Ozempic at a reduced price, Danish drugmaker Novo Nordisk said in a statement Tuesday.

The move comes as two generic versions of Ozempic and Wegovy, both produced by Novo Nordisk, have started arriving in Canadian pharmacies, which means patients who use the drug to treat diabetes or for weight loss may have more options for a fraction of the cost.

Earlier this month, Health Canada approved both Dr. Reddy’s and Apotex’s generic semaglutide — the active ingredient in brand-name Ozempic that is prescribed for diabetes and Wegovy, which is the same drug but under a different name and at a higher dose when prescribed for weight loss.

The drugs, known as GLP-1 agonists, work by triggering insulin release, blocking sugar production in your liver and making you feel full for longer by slowing the flow of food through the digestive system.

Read more: https://globalnews.ca/news/11863331/novo-nordisk-slash-ozempic-price-generics/